Skip to main content

Table 1 Clinical information of 10 patients

From: Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics

Characteristics

Value N (%) or Mean ± SD

Age

54.00 ± 10.40

Sex (Male)

10 (80%)

T1/T2 States

7 / 3

Tumor diameter (cm)

5.03 ± 2.40

Hypertension

10 (10%)

Cigarette smoking

10 (10%)

ALT, U/L

20.92 ± 14.40

AST, U/L

21.58 ± 7.49

TP, g/L

64.07 ± 10.10

TBIL, μmol/L

10.60 ± 6.08

ALP, U/L

72.37 ± 22.34

GGT, U/L

26.01 ± 13.68

TBA, μmol/L

1.94 ± 1.21

CHE, KU/L

7.94 ± 2.85

LDH, U/L

215.38 ± 42.83

GLDH-D, U/L

3.89 ± 1.75

NEFA-D, mmol/L

0.28 ± 0.17

CHOL, mmol/L

5.10 ± 0.64

TG, mmol/L

1.83 ± 0.23

HDL-C, mmol/L

1.11 ± 0.13

LDL-C, mmol/L

3.36 ± 0.53

APO-A1, g/L

1.12 ± 0.23

APOB100, g/L

1.07 ± 0.20

LPa, mg/dL

4.40 ± 1.98

UREA, mmol/L

5.78 ± 1.49

CREA, μmol/L

103.50 ± 39.03

UA, μmol/L

339.33 ± 74.27

GLU, mmol/L

5.78 ± 1.18

  1. ALT: alanine aminotransferase; AST: aspartate aminotransferase; TP: total protein; TBIL: total bilirubin; ALP: alkaline phosphatase; GGT: glutamyl transferase; TBA: total bile acid; CHE: cholinesterase; LDH: lactate dehydrogenase; GLDH-D: glutamate dehydrogenase; NEFA-D: non-estesterified fatty acid; CHOL: cholesterol; TG: triglycerides; HDL-C: high density lipoprotein; LDL-C: low density lipoprotein; APO-A1: Apolipoprotein-A1; APOB100: Apolipoprotein B100; LPa: lipoprotein; CREA: Creatinine; UA: Uric acid; GLU: Glucose